CRP and COVID-19: A CRP increase after tocilizumab treatment was also predictive of mortality, while we did not observe increased CRP levels in patients with microbiological evidence of bacterial superinfection, meaning rising CRP levels may be rather reflecting progression of COVID-19 in this situation.